{"id":393579,"date":"2020-12-04T09:33:19","date_gmt":"2020-12-04T14:33:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=393579"},"modified":"2020-12-04T09:33:19","modified_gmt":"2020-12-04T14:33:19","slug":"skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/","title":{"rendered":"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare"},"content":{"rendered":"

<\/p>\n

Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare<\/b><\/p>\n

Clinical-stage company is focused on innovation in skin health worldwide<\/b><\/p>\n

TORONTO–(BUSINESS WIRE<\/a>)–MedC Biopharma<\/a> Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, has announced the launch of its $3 million private placement offering using the DealSquare<\/a> platform, powered by NEO<\/a> and DealMaker<\/a> technology.\n<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201204005071\/en\/<\/a><\/p>\n

\"MedC<\/p>\n

MedC Biopharma Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire)<\/p>\n<\/div>\n

\nA clinical-stage biopharmaceutical company, MedC ($MEDCB) develops and commercializes cannabinoid and other natural compound-containing products for use in the consumer, veterinary, medical skin, and general health markets. The company has already developed two drugs toward clinical trials for CTCL \u2013 Skin (Cutaneous) T-cell Lymphoma and Cutaneous Leishmaniasis, both of which are recognized as orphan conditions with unmet needs, and as markets with huge potential. MedC is developing its own proprietary red sea-algae \u201cAlgel\u201d gel-based products, with a variety of applicable uses for skin health and wellness, and is also pursuing opportunities in veterinary medication and pet health, specifically oncology and inflammation-related indications (an estimated $400 million annual market).\n<\/p>\n

\nMedC\u2019s campaign marks the first capital raise through the joint service offering between DealSquare and DealMaker. DealSquare, powered by NEO, is a fully automated and centralized platform allowing capital raisers to publish their private placement opportunities, dealers to complete their due diligence, and advisors and investors to electronically subscribe to a deal. DealMaker provides the back-office technology, transaction engine, and electronic signature functionality for investors submitting orders electronically, compliantly, globally. Together, DealSquare, NEO, and DealMaker provide MedC with the smoothest transaction experience and broadest reach of capital market participants.\n<\/p>\n

\u201cThe launch of our private offering leveraging the joint service capabilities of these reputable platforms marks a significant step towards MedC taking its place amongst industry leaders that are determined to legitimize and deliver the health benefits of cannabinoids to the global community<\/i>,\u201d remarked Dr. Owen Van Cauwenberghe, President of MedC. \u201cOur tireless efforts and commitment to substantiated medical and health claims for these products will ensure that their benefits will be available to all those in need. We are fortunate to be able to take advantage of the combined DealSquare, NEO, and DealMaker offering.\u201d<\/i><\/p>\n

\nMedC\u2019s listing on DealSquare, combined with the technology of DealMaker, creates an opportunity for investors who believe there is a global need to mature and legitimize the cannabis and cannabis-related health and medical market, by supporting the development of products that deliver health and wellness benefits. With the funds raised from the campaign, MedC is targeting international expansion, initially across Canada and Australia, with plans to launch in Europe, UK, Asia, and Latin America shortly thereafter. It will also expand its product offering with new lines for different markets and multiple dose formats. There will be a strong focus on research and development of high value market products, as well as regulatory work, thus enabling MedC to further enhance its product offering.\n<\/p>\n

\u201cWe welcome MedC as our first partner in the joint initiative we have launched with DealMaker,\u201d <\/i>said Peter-Paul Van Hoeken, Managing Director of DealSquare. \u201cThe cannabis-related health and medical sector is a fast-growing market that offers attractive investment opportunities. The MedC listing enables dealers and advisors to offer this investment opportunity to their clients, and to execute investments efficiently and in a fully digitized way through our online platform.\u201d<\/i><\/p>\n

\u201cMedC is well-positioned to deliver effective medical treatments for skin conditions in a highly underserviced market, and the funds raised from this joint campaign will help make that possible,\u201d <\/i>added Rebecca Kacaba, CEO of DealMaker. \u201cWe are honoured to be powering MedC in raising the capital needed to achieve rapid growth.\u201d<\/i><\/p>\n

\u201cMedC\u2019s capital raise is truly a noteworthy event,\u201d <\/i>concluded Jos Schmitt, President and CEO of NEO. \u201cIt marks the coming together of like-minded organizations, all of whom are on a relentless pursuit of innovation for the benefit of others. By harnessing the combined strength of DealMaker and DealSquare, powered by NEO, MedC gains exposure to a wider investor community, both here in Canada and abroad.”<\/i><\/p>\n

\nTo view MedC Biopharma\u2019s private placement offering on DealSquare, click here<\/a>. For direct investor investment, click here<\/a>. The MedC Biopharma ticker is available under MEDCB on existing advisor order entry systems.\n<\/p>\n

About MedC Biopharma<\/b><\/p>\n

\nMedC Biopharma is a science-driven company focused on developing, producing, and delivering differentiated cannabinoid and other natural compound-containing products targeting the consumer, veterinary and medical skin & general health markets.\n<\/p>\n

\nConnect with MedC Biopharma: Website<\/a> | LinkedIn<\/a><\/p>\n

About DealSquare<\/b><\/p>\n

\nA joint initiative between NEO and Silver Maple Ventures, DealSquare, is Canada\u2019s first centralized dealer platform for private placements, digitally connecting capital-raisers to investment dealers, their advisory networks, and their investors. With the complete roll-out of the platform in early 2020, DealSquare supports the entire private placement process: capital raisers publish their private placement opportunities; dealers complete their due diligence; and advisors electronically subscribe to a deal, with exempt securities seamlessly integrated into client accounts and back office systems utilizing NEO technology.\n<\/p>\n

\nConnect with DealSquare: Website <\/a>| LinkedIn<\/a> | Twitter <\/a><\/p>\n

About DealMaker<\/b><\/p>\n

\nDealMaker is an innovative cloud-based platform for the capital raising and settlement of domestic and international private placements in capital markets, KYC and Fund Formation. DealMaker makes private placement transactions surprisingly pleasant, delivering speed, innovation, and efficiency to the global private capital markets. Financings using DealMaker close faster, with greater control over the process which creates a better experience. DealMaker strives for a simpler, cleaner way of doing things on one global platform.\n<\/p>\n

\nConnect with DealMaker: Website <\/a>| LinkedIn<\/a> | Twitter <\/a><\/p>\n

About NEO<\/b><\/p>\n

\nNEO is a group of established fintech companies that provide capital markets infrastructure designed for and led by the industry. NEO\u2019s competitive drive, innovation, and advocacy enable change for the better. The NEO Exchange is a progressive stock exchange that brings together investors and capital raisers within a fair, efficient, and service-oriented environment; and DealSquare, powered by NEO technology, is a platform that enables the distribution of financial assets not listed on a stock exchange in a way that reduces costs, minimizes operational risks, and improves the investor experience.\n<\/p>\n

\nConnect with NEO: Website<\/a> | Twitter<\/a>| <\/strong>LinkedIn<\/a><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201204005071\/en\/<\/a><\/span><\/p>\n

Media Contact:
\n<\/b>
DealSquare
\n<\/b>
John Hills
\n
E: John@dealsquare.io
\n<\/a>
P: 289 962 1708\n<\/p>\n

KEYWORDS:<\/b> North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Technology Research Clinical Trials Biotechnology Networks Health Data Management Other Science Science<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
MedC Biopharma Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare Clinical-stage company is focused on innovation in skin health worldwide TORONTO–(BUSINESS WIRE)–MedC Biopharma Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, has announced the launch of its $3 million private placement offering using the DealSquare platform, powered by NEO and DealMaker technology. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201204005071\/en\/ MedC Biopharma Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire) A clinical-stage biopharmaceutical company, MedC ($MEDCB) develops and commercializes cannabinoid and other natural compound-containing products … <\/p>\n

Continue reading “Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-393579","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSkin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare Clinical-stage company is focused on innovation in skin health worldwide TORONTO–(BUSINESS WIRE)–MedC Biopharma Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, has announced the launch of its $3 million private placement offering using the DealSquare platform, powered by NEO and DealMaker technology. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201204005071\/en\/ MedC Biopharma Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire) A clinical-stage biopharmaceutical company, MedC ($MEDCB) develops and commercializes cannabinoid and other natural compound-containing products … Continue reading "Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-04T14:33:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20201204005071\/en\/844205\/4\/MedC-Screenshot-Image.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare\",\"datePublished\":\"2020-12-04T14:33:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/\"},\"wordCount\":1141,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201204005071\\\/en\\\/844205\\\/4\\\/MedC-Screenshot-Image.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/\",\"name\":\"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201204005071\\\/en\\\/844205\\\/4\\\/MedC-Screenshot-Image.jpg\",\"datePublished\":\"2020-12-04T14:33:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201204005071\\\/en\\\/844205\\\/4\\\/MedC-Screenshot-Image.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201204005071\\\/en\\\/844205\\\/4\\\/MedC-Screenshot-Image.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/","og_locale":"en_US","og_type":"article","og_title":"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare - Market Newsdesk","og_description":"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare Clinical-stage company is focused on innovation in skin health worldwide TORONTO–(BUSINESS WIRE)–MedC Biopharma Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, has announced the launch of its $3 million private placement offering using the DealSquare platform, powered by NEO and DealMaker technology. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201204005071\/en\/ MedC Biopharma Corporation (\u201cMedC\u201d), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire) A clinical-stage biopharmaceutical company, MedC ($MEDCB) develops and commercializes cannabinoid and other natural compound-containing products … Continue reading \"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-04T14:33:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20201204005071\/en\/844205\/4\/MedC-Screenshot-Image.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare","datePublished":"2020-12-04T14:33:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/"},"wordCount":1141,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20201204005071\/en\/844205\/4\/MedC-Screenshot-Image.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/","name":"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20201204005071\/en\/844205\/4\/MedC-Screenshot-Image.jpg","datePublished":"2020-12-04T14:33:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20201204005071\/en\/844205\/4\/MedC-Screenshot-Image.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20201204005071\/en\/844205\/4\/MedC-Screenshot-Image.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skin-oncology-firm-medc-biopharma-launches-private-placement-offering-on-dealsquare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/393579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=393579"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/393579\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=393579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=393579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=393579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}